Cranberry Institute Showcases New Evidence: Daily Cranberry Intake Cuts H. pylori Levels by 20%
Digital Desk
The India office of The Cranberry Institute has launched a multi-city educational initiative to share groundbreaking research on how daily cranberry consumption can significantly suppress Helicobacter pylori (H. pylori) infection—a major public health challenge in India. The sessions are being conducted across New Delhi, Chennai, Mumbai, Ahmedabad, and Kolkata, bringing together leading gastroenterologists, gut health experts, and endocrinologists.
The expert panel includes:
Dr. Jignesh Gandhi, Professor of Surgery and Robotic & Gastrointestinal Surgeon, Gleneagles & Fortis Hospitals, Mumbai
Dr. Amy B. Howell, Ph.D., Associate Research Scientist, Rutgers University, USA
Dr. Vani Vijay, GI Minimal Access & Robotic Surgery Specialist, Apollo Spectra Hospitals & Gleneagles Healthcity, Chennai
Sumit Saran, India Representative, The Cranberry Institute
Each event is moderated by a senior medical specialist from the host city.
Dr. Jignesh Gandhi emphasized that nearly 60% of India’s population is affected by H. pylori. He highlighted that consuming cranberry juice twice daily for eight weeks led to a 20% reduction in infection rates, presenting a natural, well-tolerated dietary addition to standard treatments.
Sharing details of the research, Dr. Amy Howell spoke about the double-blind, randomized, placebo-controlled clinical trial involving 522 H. pylori-positive adults. The study found that cranberry juice rich in proanthocyanidins (44 mg per 240 mL) helped prevent the bacteria from adhering to the stomach lining, maintained 94% patient compliance, and reported no adverse effects.
Dr. Vani Vijay reiterated cranberries’ valuable role in supporting overall digestive wellness, while Mr. Sumit Saran noted the rising popularity and easy availability of U.S. cranberries in the Indian market.
The findings reinforce the growing importance of dietary strategies in managing H. pylori infections and reducing the risk of associated gastric complications, including stomach cancer.
